On Thursday, Vonage Holdings Corp. (NYSE:VG)’s shares declined -0.18% to $5.56.
Vonage Holdings Corp. (VG) (“the Company”), a leading provider of cloud communications services for businesses and consumers, has reached a definitive agreement to acquire privately-held iCore Netoperates, Inc. (“iCore”), a premier provider of Unified Communications-as-a-Service (UCaaS) for businesses, for $92 million.
Mr. Masarek continued, “Our strategy is to serve businesses of any size via a multi-channel distribution approach. With the addition of iCore, Vonage will have what we believe is the largest sales force in the UCaaS market, addressing mid-market and enterprise companies through a Field Sales organization that sells directly to customers and a Channel Sales organization that supports our extensive nationwide network of indirect channel partners. Vonage serves the SMB market through a highly-successful Inside Sales team augmented with Online sales. Combined with iCore, we believe we will have the broadest multi-channel distribution platform in our industry and are ideally positioned to serve the full spectrum of the UCaaS market, from SMB to mid-market to enterprise.”
Vonage Holdings Corp. provides unified communications as a service solutions connecting people through cloud-connected devices worldwide. The company offers home telephone replacement services to residential customers through various service plans with basic features, such as voicemail, call waiting, call forwarding, simulring, visual voicemail, and extensions, in addition to area code selection, virtual phone number, and Web-enabled voicemail. Its primary residential offering comprises Vonage World that offers unlimited domestic calling; calling to landline phones in about 60 countries; calling to mobile phones in various countries; and voicemail with Vonage Visual Voicemail.
BioDelivery Sciences International, Inc. (NASDAQ:BDSI)’s shares dropped -2.66% to $6.23.
BioDelivery Sciences International, Inc. (BDSI) declared the approval by the U.S. Food and Drug Administration (FDA) of a Supplemental New Drug Application (sNDA) for a new formulation of ONSOLIS® (fentanyl buccal soluble film) CII for the administration of breakthrough pain in patients with cancer who are opioid tolerant. The new formulation was presented to address formerly declared appearance-related changes.
Early this year, BDSI declared that it reached an assignment and revenue sharing agreement with its partner for ONSOLIS, Meda Pharmaceuticals, to return the marketing authorization back to BDSI and the right to seek marketing authorizations for ONSOLIS in the United States, Canada and Mexico. Meda retains the rights to ONSOLIS outside the U.S., where it is marketed in the E.U. as BREAKYL. ONSOLIS is separately licensed by BDSI in Taiwan and South Korea.
BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products principally in the areas of pain administration and addiction. The company provides its products based on its patented BioErodible MucoAdhesive (BEMA) drug delivery technology, which comprises of a small, bi-layered erodible polymer film for application to the buccal mucosa.
At the end of Thursday’s trade, Live Nation Entertainment, Inc. (NYSE:LYV)‘s shares surged 1.60% to $24.73.
Live Nation Entertainment, Inc. (LYV), the world’s leading live entertainment and ecommerce company, declared recently that Michael Rapino, Live Nation Entertainment’s President and Chief Executive Officer, will be presenting at the Goldman Sachs Communacopia Conference, on Thursday, September 17, 2015 at 3:45 p.m. ET. During his presentation, Mr. Rapino may make observations regarding the company’s financial performance and outlook.
Live Nation Entertainment, Inc. operates as a live entertainment company. The company operates through Concerts, Ticketing, Artist Nation, and Sponsorship & Advertising segments. The Concerts segment promotes live music events in its owned and/or operated venues, and in rented third-party venues; operates and manages music venues; and produces music festivals. The Ticketing segment manages the ticketing operations, counting providing ticketing software and services to clients, ticket resale services, and online access for customers regardingticket and event information through its primary Websites, www.livenation.com and www.ticketmaster.com.
Firstmerit Corp (NASDAQ:FMER), ended its Thursday’s trading session with 0.52% gain, and closed at $17.46.
FirstMerit Corporation (FMER) declared that its Board of Directors has declared a dividend of $14.69 per share, or $0.36725 per depository share, on the Company’s 5.875% non-cumulative perpetual preferred stock, Series A, payable November 4, 2015, to shareholders of record on October 20, 2015.
FirstMerit Corporation operates as the bank holding company for FirstMerit Bank N.A. that provides various banking, fiduciary, financial, insurance, and investment services to corporate, institutional, and individual customers. The company’s Commercial segment offers commercial term loans, revolving credit arrangements, asset-based lending, leasing, commercial mortgages, real estate construction lending, and letters of credit, in addition to treasury administration, government banking, international banking, merchant card, and other depository products and services. Its Retail segment provides retail financial products and services, counting consumer direct and indirect installment loans, debit and credit cards, debit gift cards, residential mortgage loans, home equity loans and lines of credit, deposit products, fixed and variable annuities, and ATM network services. This segment also offers deposit products comprising checking, savings, and money market accounts, in addition to certificates of deposit.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
